AMPH — Amphastar Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.12bn
- $1.45bn
- $719.89m
Brief: Amphastar Pharmaceuticals posts Q1 EPS USD 0.5
Amphastar Pharmaceuticals Inc expected to post earnings of 48 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
Amphastar Pharma slips on deal to buy Eli Lilly's low blood sugar drug
Deals of the day-Mergers and acquisitions
Eli Lilly to sell low blood sugar drug to Amphastar (updated)
Eli Lilly to sell low blood sugar drug to Amphastar
Brief: Lilly To Divest Baqsimi To Amphastar
Brief: Amphastar Pharmaceuticals Inc On March 8 Co And Nanjing Hanxin Pharmaceutical Technology Entered Amendment To Contract Research Agreement
U.S. FDA approves Amphastar Pharma's nasal spray for opioid overdose
U.S. RESEARCH ROUNDUP-Itron, Marathon Petroleum, Radius Global Infrastructure
Amphastar Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Amphastar Pharmaceuticals Inc - QTRLY GAAP Net Income Of $0.66 Per Share
Amphastar Pharmaceuticals Inc expected to post earnings of 41 cents a share - Earnings Preview
Brief: Amphastar Pharmaceuticals Inc Says On Nov 15, Co's Unit Entered Into A Supply Agreement With Nanjing Letop Biotechnology Co.
Amphastar Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Amphastar Pharmaceuticals Inc Reports Net Revenues Of $120.1 Million For The Third Quarter
Amphastar Pharmaceuticals Inc expected to post earnings of 39cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Arista Networks, Planet Fitness, Tricida